tiprankstipranks
Trending News
More News >
Asahi Intecc Co Ltd (JP:7747)
:7747

Asahi Intecc Co (7747) AI Stock Analysis

Compare
2 Followers

Top Page

JP:7747

Asahi Intecc Co

(7747)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 5.2)
Rating:68Neutral
Price Target:
¥2,801.00
▼(-5.15% Downside)
Asahi Intecc Co's overall stock score is driven by strong financial performance, highlighted by robust revenue growth and efficient cash flow management. However, technical indicators suggest overbought conditions, and the high P/E ratio indicates potential overvaluation, which tempers the overall score.
Positive Factors
Durable Revenue Growth
Consistent double-digit revenue growth (13–17% range) reflects expanding adoption of minimally invasive devices, successful international distribution across Japan, the U.S. and Europe, and focused R&D. Structural demand in interventional cardiology supports sustained top-line expansion over multiple years.
High Gross Margins
A very high gross margin (~65%) indicates strong product differentiation, manufacturing expertise and pricing power in specialized guide wires and catheters. Durable margins provide room to fund R&D, absorb volume swings, and underpin long-term operating profitability if product mix and premium positioning persist.
Strong Cash & Low Leverage
Very low leverage (D/E 0.07) combined with robust cash generation and solid free-cash-flow conversion supports financial flexibility. This durable balance sheet allows the company to fund R&D, expand manufacturing capacity, and weather cyclical healthcare spending without relying on external debt.
Negative Factors
Margin Compression Risk
Observed declines in EBIT and EBITDA margins suggest rising operating costs, product-mix shifts or pricing pressures. If persistent, this reduces operating leverage and free cash available for strategic investment, making margin recovery a structural priority for sustained profitability over quarters.
Weakening Return on Equity
A modest ROE of ~8.5% that has declined signals that incremental capital is generating lower returns. Persistently weak ROE can constrain shareholder value creation and implies either margin improvement or better asset efficiency is needed to convert revenue growth into attractive long-term returns.
Negative EPS Growth
Negative EPS growth despite revenue gains suggests earnings are being eroded by margin pressure, higher operating costs, or one-time impacts. Continued EPS decline can limit self-funding for R&D, slow per-share value accretion, and necessitate structural cost or pricing actions to restore earnings momentum.

Asahi Intecc Co (7747) vs. iShares MSCI Japan ETF (EWJ)

Asahi Intecc Co Business Overview & Revenue Model

Company DescriptionAsahi Intecc Co., Ltd. engages in the development, manufacture, and sale of medical devices in Japan, the United States, Europe, the Middle East, China, and internationally. The company provides percutaneous transluminal coronary angioplasty (PTCA) guide wires, PTCA guiding catheters, PTCA balloon catheters, and penetration catheters for cardiology; peripheral guide wires, IVR guide wires, micro catheters, and cerebrovascular system guide wires for peripheral vascular, abdominal vascular, and cerebrovascular systems; and guide wires and catheters for angiography. It also offers OEM services for medical devices; and medical and industrial components, such as element wires, stranded conductors, coils, tubes, terminal processing products, and other products, as well as develops, manufactures, and sells ultra-fine stainless steel wire ropes, terminal processed products, etc. The company was formerly known as Asahi Mini Rope Sales Co., Ltd. and changed its name to Asahi Intecc Co., Ltd. in July 1988. Asahi Intecc Co., Ltd. was incorporated in 1976 and is headquartered in Aichi, Japan.
How the Company Makes MoneyAsahi Intecc generates revenue primarily through the sale of its medical devices, particularly its advanced guide wires and catheters used in interventional procedures. The company has established a strong presence in markets around the world, including Japan, the United States, and Europe, which contributes to its diverse revenue streams. Key partnerships with hospitals, clinics, and healthcare providers facilitate the distribution of its products. Additionally, Asahi Intecc invests in research and development to innovate and expand its product offerings, which helps to maintain its competitive edge and drive sales growth. The company also benefits from the increasing demand for minimally invasive surgical procedures, further enhancing its revenue potential.

Asahi Intecc Co Financial Statement Overview

Summary
Asahi Intecc Co demonstrates solid financial health with strong revenue growth and efficient cash flow management. The company maintains a stable balance sheet with low leverage, although there is a slight decline in profitability margins.
Income Statement
85
Very Positive
Asahi Intecc Co has demonstrated strong revenue growth over the years, with a notable increase of 17.7% in the most recent year. The company maintains a healthy gross profit margin of 65.18% and a solid net profit margin of 10.61%. However, there is a slight decline in EBIT and EBITDA margins compared to previous years, indicating some pressure on operational efficiency.
Balance Sheet
78
Positive
The company exhibits a strong balance sheet with a low debt-to-equity ratio of 0.07, indicating prudent financial leverage. The return on equity stands at 8.46%, which, while positive, has decreased from previous years, suggesting a need for improved profitability. The equity ratio remains robust, reflecting a stable financial position.
Cash Flow
82
Very Positive
Asahi Intecc Co shows impressive growth in free cash flow, with a significant increase in the latest period. The operating cash flow to net income ratio is strong at 1.46, indicating efficient cash generation relative to earnings. The free cash flow to net income ratio of 0.80 suggests a healthy conversion of earnings into cash, although there is room for improvement.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue120.03B120.03B107.55B90.10B77.75B61.51B
Gross Profit81.24B78.23B69.05B58.83B51.08B41.47B
EBITDA29.16B29.02B31.73B26.73B23.34B18.20B
Net Income12.74B12.74B15.81B13.11B10.86B9.98B
Balance Sheet
Total Assets193.19B193.19B191.61B172.64B155.13B115.43B
Cash, Cash Equivalents and Short-Term Investments54.20B54.20B38.66B36.88B32.32B21.36B
Total Debt11.10B11.10B6.70B14.25B12.18B8.04B
Total Liabilities41.83B41.83B39.65B38.35B34.00B22.49B
Stockholders Equity150.56B150.56B151.22B132.31B119.46B92.91B
Cash Flow
Free Cash Flow0.0032.45B24.83B6.85B9.32B-986.00M
Operating Cash Flow0.0040.54B34.71B19.14B17.30B8.92B
Investing Cash Flow0.00-13.43B-21.22B-15.13B-18.70B-16.33B
Financing Cash Flow0.00-8.11B-13.88B-2.34B11.37B10.11B

Asahi Intecc Co Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2953.00
Price Trends
50DMA
2921.66
Negative
100DMA
2693.98
Negative
200DMA
2505.43
Positive
Market Momentum
MACD
-80.18
Positive
RSI
20.94
Positive
STOCH
6.40
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7747, the sentiment is Negative. The current price of 2953 is above the 20-day moving average (MA) of 2849.20, above the 50-day MA of 2921.66, and above the 200-day MA of 2505.43, indicating a neutral trend. The MACD of -80.18 indicates Positive momentum. The RSI at 20.94 is Positive, neither overbought nor oversold. The STOCH value of 6.40 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7747.

Asahi Intecc Co Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
¥149.95B30.342.73%5.10%-26.13%
68
Neutral
¥681.88B45.6410.09%0.82%13.53%-7.39%
68
Neutral
¥2.98T22.799.31%1.22%7.68%10.08%
68
Neutral
¥2.03T21.2013.13%1.01%0.42%34.76%
66
Neutral
¥182.50B27.085.66%2.66%5.43%-20.67%
62
Neutral
¥231.60B21.274.38%2.03%6.04%733.13%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7747
Asahi Intecc Co
2,570.00
42.66
1.69%
JP:4543
Terumo
2,017.50
-799.57
-28.38%
JP:7716
Nakanishi
2,162.00
-259.81
-10.73%
JP:8086
Nipro
1,420.00
20.35
1.45%
JP:7733
Olympus
1,841.00
-401.55
-17.91%
JP:7730
Mani, Inc.
1,522.00
167.62
12.38%

Asahi Intecc Co Corporate Events

Asahi Intecc Unveils Integrated Report 2025 Highlighting New Medium-Term Plan and Governance
Dec 26, 2025

Asahi Intecc has published its “Integrated Report 2025” on its website, consolidating financial and non-financial information to explain how the group intends to enhance corporate value over the long term. Centered on the company’s newly launched medium-term management plan, the report details the group’s medium- to long-term vision, specific strategies and measures for sustainable growth, and a roadmap that builds on its technological strengths and operational capabilities. It also incorporates perspectives from external analysts on the objectives and priority areas of the new plan, as well as the company’s approach to growth and financial strategy, offering stakeholders a multi-dimensional view of the plan’s background and execution resolve. In addition, the report highlights the effectiveness of the Board of Directors through dialogues with outside directors, interviews with audit and supervisory members, and commentary from a former outside director, showcasing the company’s governance framework and oversight functions as it strives to be a trusted, continuously growing enterprise.

The most recent analyst rating on (JP:7747) stock is a Hold with a Yen3153.00 price target. To see the full list of analyst forecasts on Asahi Intecc Co stock, see the JP:7747 Stock Forecast page.

Asahi Intecc Completes Treasury Share Cancellation
Nov 28, 2025

Asahi Intecc Co., Ltd. has completed the cancellation of 6,301,300 treasury shares, representing 2.3% of its total common shares, as resolved by its Board of Directors. This strategic move is expected to optimize the company’s capital structure and potentially enhance shareholder value by reducing the number of outstanding shares.

The most recent analyst rating on (JP:7747) stock is a Hold with a Yen3153.00 price target. To see the full list of analyst forecasts on Asahi Intecc Co stock, see the JP:7747 Stock Forecast page.

Asahi Intecc Reports Strong Q3 Financial Performance
Nov 14, 2025

Asahi Intecc Co., Ltd. reported significant growth in its financial performance for the three months ending September 30, 2025, with net sales rising by 15.6% and operating profit increasing by 34% compared to the previous year. This robust performance underscores the company’s strong market position and operational efficiency, with a notable 360.6% increase in comprehensive income, reflecting its strategic focus and effective management practices.

The most recent analyst rating on (JP:7747) stock is a Hold with a Yen2678.00 price target. To see the full list of analyst forecasts on Asahi Intecc Co stock, see the JP:7747 Stock Forecast page.

Asahi Intecc Completes Treasury Share Acquisition
Oct 31, 2025

Asahi Intecc Co., Ltd. has completed the acquisition of 1,206,800 treasury shares, amounting to approximately 2.85 billion yen, as part of a broader plan approved by the Board of Directors in May 2025. This strategic move, which concluded on October 30, 2025, is part of the company’s efforts to enhance shareholder value and optimize its capital structure, having acquired a total of 6,301,300 shares by the end of the acquisition period.

The most recent analyst rating on (JP:7747) stock is a Hold with a Yen2525.00 price target. To see the full list of analyst forecasts on Asahi Intecc Co stock, see the JP:7747 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 22, 2025